Policy & Equity
Government Launches Healthcare Fraud Crackdowns, Raising New Privacy Concerns
New federal anti-fraud efforts are creating a cross-agency monitoring system, raising new concerns about patient privacy.
6/23/2026
New federal anti-fraud efforts are creating a cross-agency monitoring system, raising new concerns about patient privacy.
Competition in the obesity treatment market grows as Eli Lilly’s retatrutide moves closer to FDA submission.
The technology aims to improve consistency in embryo selection decisions, while offering support to professionals
Lawsuits in Georgia, Alabama and Mississippi challenge rules that bar direct-entry midwives.
The U.S. Food and Drug Administration made a significant step in the use of predictive algorithms for sepsis detection care. The FDA cleared the first AI-based early-warning system designed to detect sepsis in hospitalized patients. The John Hopkins University developed the Targeted Real-Time Early Warning System to use real-time patient data from electronic health records […]
Federal regulators are seeking to reposition psilocybin and other psychedelic treatments from fringe to clinical practice.
Recent studies revealed potential safety risks in ChatGPT Health, leading to growing concern for AI.
A new genetic study is clarifying why all patients don’t lose weight while using GLP-1s.
The technology company’s recent health integration update highlights the evolution of AI in the healthcare industry
Federal leadership for the nation’s top health agencies is changing as the administration shifts focus.
As enhanced Affordable Care Act subsidies disappear, major insurers are retreating from the marketplace
Utah’s historic launch of the first AI doctor authorized to prescribe medication has triggered fierce backlash from the state’s medical board. In a letter sent to the Utah Department of Commerce, the Utah Medical Licensing Board called for immediate suspension of the pilot program. The board requested further investigation into the safety and implementation of […]